Used in pharmaceutical research as a potent inhibitor of specific kinase enzymes involved in inflammatory pathways and cancer progression. Shows promising activity in preclinical studies for targeting tyrosine kinase receptors, particularly those associated with tumor growth and metastasis. Its structure allows for high selectivity and binding affinity, making it a candidate for development in oncology therapeutics. Also investigated for autoimmune disease treatment due to its modulation of immune cell signaling. Solubility and stability properties support formulation in oral dosage forms for experimental trials.